King Wealth Management Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

King Wealth Management Group’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$465K	–	185
2021 Q4	$465K	Buy	+5,000	New	+$329K	0.09%	102

King Wealth Management Group's ARNA Position: Q1 2022 in Review

King Wealth Management Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,000 shares — an estimated $465K sold.

King Wealth Management Group first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $465K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

King Wealth Management Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
King Wealth Management Group sold 5,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $465K.
King Wealth Management Group first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
King Wealth Management Group's Arena Pharmaceuticals Inc position peaked at $465K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on King Wealth Management Group's 13F filing for Q1 2022, filed 12 May 2022.